Dr Gillian Caughey

Excludes commercial-in-confidence projects.

Research since 2008 is shown below. To see earlier years visit ResearcherID or Scopus

Open access indicates that an output is open access.

Journal Articles

Conferences

Funded by the BUPA Health Foundation, my curent research in collaboration with Dr Lisa Kalisch is the 'Development of Australian clinical indicators for potentially preventable hospitalisations'. In Australia, over 90,000 hospitalisations per year are considered potentially preventable, and are estimated to cost the healthcare system $330 million annually. With administrative health databases, it is now possible to identify and routinely monitor clinical indicators of potentially preventable hospitalisations. Clinical indicators have been developed internationally; however, none have been developed specifically for the Australian setting.The aim of this study is to develop and validate Australian clinical indicators of potentially preventable medication-related and primary care-related hospitalisations. The prevalence of hospitalisations based on these indicators will be examined in a population-based administrative health database.The potential to identify patterns of preventable hospitalisation through existing data sets has great possibilities for avoiding adverse events, improving health outcomes and improving standards of care.

Bupa Health Foundation, NHMRC / ARC Ageing Well, Ageing Productively Program Grant over 5 years entitled "The development and evaluation of management strategies designed to address multimorbidity in older people: Implications for health policy planning, practitioners and patients".This study aims to identify, develop and evaluate management strategies for older people with multiple chronic conditions. Two large Australian linked health datasets, are being studied to determine the current prevalence and patterns of polymorbidity, medication use and treatment strategies in Australians aged above 50 years.This research will lead to the development of practical treatment algorithms to assist health professionals, at the point of patient care, prioritise management strategies and achieve the best possible outcomes for older Australians with common combinations of chronic conditions.

2011-2014 Development and evaluation of new anti-inflammatory products based on a traditional Indigenous medicine NHMRC Development Grant $269,590 Dr S Semple, Prof R. McKinnon, Dr J Wang, Dr GE Caughey, Dr M Constabile This project aims to develop and demonstrate the safety and efficacy of new anti-inflammatory products, from the Northern Kaanju medicinal plant Dodonaea polyandra, in collaboration with the Chuulangun Aboriginal Corporation traditional owners from the Northern Kaanju homelands in far-north QLD.

Current research interests include Pharmacoepidemiology and practice-based research.

Previous research work has included both biochemical and clinical studies in Rheumatoid Arthritis and Osteoarthritis. These include examining the roles of specific isotypes of cyclooxygenase (COX), an enzyme central to eicosanoid production, with a particular focus on the effect of inhibition of COX-2 by both traditional NSAIDs and the newly developed selective COX-2 inhibitors.I also studied the regulation of COX by specific cellular interactions and by hypoxia a condition that arises in both inflamed joints and vessel occlusions. These studies were published in highly regarded journals and successful grant funding.